InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,934.80
(
-2.46%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.30
(
-3.35%
)
Bitcoin
62,875.14
(
-3.79%
)
Post# of 516
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

wplong89

Send PM Follow Ignore
Followers 29
Posts 3135
Boards Moderated 0
Alias Born 01/14/2010

wplong89

Re: umiak post# 56

Friday, 04/01/2016 10:09:31 AM

Friday, April 01, 2016 10:09:31 AM

Post# of 516
The biggest thing about BIND to me in the iNSITE 1 and iNSITE 2 trials is the potential to show "a safer version of chemotherapy". The drug the company is using, docetaxel, also known as Taxotere, is having issues with causing permanent hair loss because of the potency.

The FDA is very aware of the issue and had a safety label change on it a couple months ago. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm212079.htm

If the company can lessen the severe side effects of chemo via targeting that would be amazing. Fingers crossed.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up